Thus, the results of our study support future studies to test the efficacy of targeting DUSP1 in various glomerulonephritis and researchers may particularly focus on the validation of the benefits of DUSP1 restoration by in vivo experiments. The gene discussed is DUSP1; the disease is glomerulonephritis.